Classification of Mild Cognitive Impairment and Alzheimer Disease Using Model-Based MR and Magnetization Transfer Imaging

References

1. 1.↵
   1. Roe CM,
   2. Fitzpatrick AL,
   3. Xiong C,
   4. et al

   . Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010;74:106–12

   CrossRef
2. 2.↵
   1. Dickerson BC,
   2. Stoub TR,
   3. Shah RC,
   4. et al

   . Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011;76:1395–402

   CrossRefPubMed
3. 3.↵
   1. Haller S,
   2. Lovblad KO,
   3. Giannakopoulos P

   . Principles of classification analyses in mild cognitive impairment (MCI) and Alzheimer disease. J Alzheimers Dis 2011;26(suppl 3):389–94

   CrossRefPubMed
4. 4.↵
   1. Chupin M,
   2. Hammers A,
   3. Liu RS,
   4. et al

   . Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. Neuroimage 2009;46:749–61

   CrossRefPubMed
5. 5.↵
   1. Calvini P,
   2. Chincarini A,
   3. Gemme G,
   4. et al

   . Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys 2009;36:3737–47

   CrossRefPubMed
6. 6.↵
   1. Whitwell JL,
   2. Shiung MM,
   3. Przybelski SA,
   4. et al

   . MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008;70:512–20

   CrossRef
7. 7.↵
   1. Chincarini A,
   2. Bosco P,
   3. Calvini P,
   4. et al

   . Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage 2011;58:469–80

   CrossRefPubMed
8. 8.↵
   1. Jack CR Jr.

   . Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 2012;263:344–61

   CrossRefPubMed
9. 9.↵
   1. Kabani NJ,
   2. Sled JG,
   3. Shuper A,
   4. et al

   . Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med 2002;47:143–48

   CrossRefPubMed
10. 10.↵
    1. van der Flier WM,
    2. van den Heuvel DM,
    3. Weverling-Rijnsburger AW,
    4. et al

    . Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52:62–67

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Ropele S,
    2. Schmidt R,
    3. Enzinger C,
    4. et al

    . Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease. AJNR Am J Neuroradiol 2012;33:570–75

    Abstract/FREE Full Text
12. 12.↵
    1. Stanisz GJ,
    2. Yoon RS,
    3. Joy ML,
    4. et al

    . Why does MTR change with neuronal depolarization? Magn Reson Med 2002;47:472–75

    CrossRefPubMed
13. 13.↵
    1. Sled JG,
    2. Pike GB

    . Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med 2001;46:923–31

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Stanisz GJ,
    2. Odrobina EE,
    3. Pun J,
    4. et al

    . T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507–12

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kiefer C,
    2. Brockhaus L,
    3. Cattapan-Ludewig K,
    4. et al

    . Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging. Neuroimage 2009;48:657–67

    CrossRefPubMed
16. 16.↵
    1. Giulietti G,
    2. Bozzali M,
    3. Figura V,
    4. et al

    . Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains. Neuroimage 2012;59:1114–22

    CrossRefPubMed
17. 17.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

    CrossRefPubMed
18. 18.↵
    1. Petersen RC

    . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Jeon YH,
    2. Sansoni J,
    3. Low LF,
    4. et al

    . Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry 2011;19:403–15

    CrossRefPubMed
20. 20.↵
    1. McKhann GM

    . Changing concepts of Alzheimer disease. JAMA 2011;305:2458–59

    CrossRefPubMedWeb of Science
21. 21.↵
    1. MacFall JR,
    2. Wehrli FW,
    3. Breger RK,
    4. et al

    . Methodology for the measurement and analysis of relaxation times in proton imaging. Magn Reson Imaging 1987;5:209–20

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Haase A

    . Snapshot FLASH MRI: applications to T1, T2, and chemical-shift imaging. Magn Reson Med 1990;13:77–89

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Deichmann R,
    2. Adolf H,
    3. Kuchenbrod E,
    4. et al

    . Compensation of diffusion effects in T2 measurements. Magn Reson Med 1995;33:113–15

    CrossRefPubMed
24. 24.↵
    1. Deichmann R,
    2. Adolf H,
    3. Noth U,
    4. et al

    . Fast T2-mapping with snapshot flash imaging. Magn Reson Imaging 1995;13:633–39

    CrossRefPubMed
25. 25.↵
    1. Bobinski M,
    2. de Leon MJ,
    3. Wegiel J,
    4. et al

    . The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000;95:721–25

    PubMedWeb of Science
26. 26.↵
    1. Mosconi L,
    2. Brys M,
    3. Glodzik-Sobanska L,
    4. et al

    . Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol 2007;42:129–38

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Fennema-Notestine C,
    2. Hagler DJ Jr.,
    3. McEvoy LK,
    4. et al

    . Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 2009;30:3238–53

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Walhovd KB,
    2. Fjell AM,
    3. Dale AM,
    4. et al

    . Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging 2010;31:1107–21

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Teslic L,
    2. Hartmann B,
    3. Nelles O,
    4. et al

    . Nonlinear system identification by Gustafson-Kessel fuzzy clustering and supervised local model network learning for the drug absorption spectra process. IEEE Trans Neural Netw 2011;22:1941–51

    CrossRefPubMed
30. 30.↵
    1. Ridha BH,
    2. Tozer DJ,
    3. Symms MR,
    4. et al

    . Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007;244:832–37

    CrossRefPubMed
31. 31.↵
    1. Paajanen T,
    2. Hanninen T,
    3. Tunnard C,
    4. et al

    . CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study. J Alzheimers Dis 2010;22:1089–97

    PubMed
32. 32.↵
    1. Braak H,
    2. Braak E

    . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–59

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Braak H,
    2. Braak E

    . Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 1994;15:355–56, discussion 379–80

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Braak H,
    2. Thal DR,
    3. Ghebremedhin E,
    4. et al

    . Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960–69

    CrossRefPubMed
35. 35.↵
    1. Stranahan AM,
    2. Mattson MP

    . Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast 2010:2010;108190

    CrossRefPubMed
36. 36.↵
    1. Cuingnet R,
    2. Gerardin E,
    3. Tessieras J,
    4. et al

    . Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage 2011;56:766–81

    CrossRefPubMed
37. 37.↵
    1. Wilkosz PA,
    2. Seltman HJ,
    3. Devlin B,
    4. et al

    . Trajectories of cognitive decline in Alzheimer's disease. Int Psychogeriatr 2010;22:281–90

    CrossRefPubMed